Unibest 优贝德
← Back to patent-cliff list

CAS 417721-14-3

4-(((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)-2-methoxybenzonitrile

Codes:LENT-004

Application context (from source-drug indications)

肾细胞癌甲磺酸仑伐替尼子宫内膜癌甲磺酸仑伐替尼肝细胞癌甲磺酸仑伐替尼甲状腺瘤甲磺酸仑伐替尼

Source drugs (routes using this intermediate)

DrugTierExpiry
甲磺酸仑伐替尼Lenvatinib MesilateTier A — Act now2028

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Unibest Taizhou GMP-like Site4-Chloro-7-methoxyquinoline -6-carboxylic acid methyl ester
Pharmaceutical Intermediates
询价询价询价
—
Qualified Partner — East China API Works4-Chloro-7-methoxyquinoline -6-carboxamide
Pharmaceutical Intermediates
询价询价询价
—
Unibest Nantong cGMP SiteN-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site4-Amino-3-chlorophenol
Pharmaceutical Intermediates
询价询价询价
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.